The perfect trio to decrease mortality in pancreatic cancers: Molecular marker screening tests with biosensors in precancerous lesions

Authors

DOI:

https://doi.org/10.3126/ajms.v14i12.58814

Keywords:

Pancreatic cancer; Precancereous-precancerous-lesions; Molecular markers; Biosensors

Abstract

The mortality rates of pancreatic cancer (PC) are very high. The methods recommended in the studies conducted to date have been able to reduce mortality very little. This study aimed to review studies on this subject and to identify the most appropriate methods to decrease mortality in PCs. Therefore, research articles and reviews on this subject were analyzed intensely, and the findings were summarized. According to the results obtained in our study, to decrease mortality in pancreatic ductal adenocarcinomas, early diagnostic screening should be performed primarily with molecular markers and biosensors effective in precancerous lesions in risk groups. However, studies on such screening worldwide have not yet been conducted. Therefore, further research is needed to arrive at more precise conclusions.

Downloads

Download data is not yet available.
Abstract
52
PDF
69

Downloads

Published

2023-12-01

How to Cite

Hasan Zafer Acar, & Nazmi Özer. (2023). The perfect trio to decrease mortality in pancreatic cancers: Molecular marker screening tests with biosensors in precancerous lesions. Asian Journal of Medical Sciences, 14(12), 267–277. https://doi.org/10.3126/ajms.v14i12.58814

Issue

Section

Review Articles